454 related articles for article (PubMed ID: 8618580)
1. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
2. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients.
Ma H; Yang RF; Wei L
J Gastroenterol Hepatol; 2010 Sep; 25(9):1498-506. PubMed ID: 20796146
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients with chronic hepatitis B after interferon treatment.
Teuber G; Dienes HP; Meyer Zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1996 Apr; 34(4):230-6. PubMed ID: 8686350
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
[TBL] [Abstract][Full Text] [Related]
5. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm SW
Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
[TBL] [Abstract][Full Text] [Related]
9. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
[TBL] [Abstract][Full Text] [Related]
10. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic hepatitis B.
Wilt TJ; Shamliyan T; Shaukat A; Taylor BC; MacDonald R; Yuan JM; Johnson JR; Tacklind J; Rutks I; Kane RL
Evid Rep Technol Assess (Full Rep); 2008 Oct; (174):1-671. PubMed ID: 19408969
[TBL] [Abstract][Full Text] [Related]
14. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
Moucari R; Korevaar A; Lada O; Martinot-Peignoux M; Boyer N; Mackiewicz V; Dauvergne A; Cardoso AC; Asselah T; Nicolas-Chanoine MH; Vidaud M; Valla D; Bedossa P; Marcellin P
J Hepatol; 2009 Jun; 50(6):1084-92. PubMed ID: 19376603
[TBL] [Abstract][Full Text] [Related]
15. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
Lin ZQ; Fang F; Guo ZF; Chen Q
Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
[TBL] [Abstract][Full Text] [Related]
16. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
